If you use a continuous glucose monitoring (CGM) system, you usually have to remove the sensor before any imaging tests like ...
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack’s CBGM is a long-term, implantable system that ...
England's NHS is testing an artificial pancreas for children with Type 1 diabetes, a device already available in India.
The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.
NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...